LOS ANGELES – “Octomom” Nadya Suleman’s Beverly Hills fertility doctor implanted too many embryos in one patient, resulting in the death of a fetus, and failed to refer another woman to a cancer specialist after finding cysts on her ovaries, the state licensing board said.

The new allegations by the Medical Board of California bolster its ongoing negligence case against Dr. Michael Kamrava.

The board said a 48-year-old patient identified only as “L.C.” was implanted with seven embryos in September 2008 — several months after Suleman, 33, had embryos implanted.

Implanting more than two embryos in a patient over age 35 meant that Kamrava “placed L.C. at great risk for high-order gestation, which was confirmed by a quadruplet pregnancy that ended with catastrophic results,” the filing said.

Kamrava is scheduled for an Oct. 18 hearing before the medical board to determine if his license should be revoked or suspended. His publicist David Langness and his lawyer Henry Fenton said they could not comment on the open case.

Kamrava has declined repeated interview requests from The Associated Press and other news organizations. An interview given to “Nightline” on ABC was slated to air Tuesday night.

In the interview, Kamrava said the Suleman fertility treatment was “done the right way.”

The state medical board has not disclosed the number of embryos Suleman had implanted but said the number was far in excess of recommendations and “beyond the reasonable judgment of any treating physician.”

Suleman has said six were implanted, and two of the embryos split. She gave birth in January 2009.

The latest allegations against Kamrava were noted by the board when its case was updated June 30.

The filing said four of the seven embryos implanted in “L.C.” became viable. She lost one during pregnancy and gave birth to triplets, one of whom has profound developmental delays.

In another similarity to the Suleman case, Kamrava is accused of failing to refer “L.C.” to receive appropriate counseling before undergoing fertility treatments — “omissions which constitute an extreme departure from the standard of practice,” according to the filing.

Kamrava also was accused by the board of failing to refer another patient identified as “H.L.” for cancer screening, despite her history of the disease and his discovery of cysts on her ovaries in an ultrasound.

After draining fluid from the cysts and testing for cancerous cells, Kamrava ruled out cancer on his own “rather than refer H.L. to a specialist for further evaluation,” according to the filing.

Kamrava continued with fertility treatments, performing an embryo transfer for the woman in January 2009, but the pregnancy did not take, the report states.

Afterward, the patient went to two more fertility specialists who both recommended she undergo surgery to rule out cancer.

Following surgery in April 2009, “H.L.” was diagnosed with metastatic, stage III bilateral ovarian cancer and had to have her uterus, cervix, ovaries and fallopian tubes removed, the report states.

 

Copy the Story Link